OMER
Omeros Corporation
NASDAQ: OMER · HEALTHCARE · BIOTECHNOLOGY
$17.88
+2.23% today
Updated 2026-10-28
Market cap
$1.22B
P/E ratio
13.28
P/S ratio
31.76x
EPS (TTM)
$1.27
Dividend yield
—
52W range
$6 – $21
Volume
1.4M
Omeros Corporation (OMER) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.88
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$94.46
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 13.28x (capped 25x) · Margin: 324.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.